Accessibility Menu
Anagenics Ltd logo

Anagenics Ltd(ASX) AN1

Market CapA$5.91MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2005)-100%
5 Year-87%
1 Year+40%
1 Month+0%
A$0.01
+16.67%
+0.00Today
Anagenics Ltd last closing stock price
MetricPriceDate
Last closeAUD 0.012026-07-30
Anagenics Ltd stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+16.67%AUD 0.012026-07-21
1 month+0%AUD 0.012026-06-30
3 month+16.67%AUD 0.012026-04-30
Year to date+40%AUD 0.012025-12-31
1 year+40%AUD 0.012025-07-23
3 year-61.11%AUD 0.022023-07-31
5 year-87.27%AUD 0.062021-07-30
Since inception-99.8%AUD 3.562005-12-09

Anagenics Ltd Financials at a Glance

Market Cap

A$5.91MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

A$11.95M

Net Income (TTM)

-A$6.65M

EPS (TTM)

-A$0.00

P/E Ratio

-4.29

Dividend

A$0.00

Beta (Volatility)

0.11 (Low)

Price

A$0.01

Volume

0

Open

A$0.01

Previous Close

A$0.01

Daily Range

A$0.01 - A$0.01

52-Week Range

A$0.00 - A$0.01

Estimated Earnings Date

Sep 2, 2026

AN1 News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Anagenics Ltd

Anagenics Limited is a company focused on the health, wellness, and beauty sectors. It develops and markets anti-aging hair care products under the évolis brand and skin, hair, and body care products under the Uspa brand. The company also imports and distributes various wellness products across Australia, New Zealand, and the Pacific Islands.

Products and Services
  • Anti-aging hair care products under the évolis brand
  • Skin, hair, and body care products under the Uspa brand
  • Distribution of wellness products to spas, clinics, and retail stores
Growth Outlook
  • Recent quarterly revenue reached AUD 2.64 million, showing strong demand
  • Gross profit margin improved to 53.2% in the latest quarter
  • Expansion plans include increasing distribution channels in the Pacific Islands
Financial Highlights
  • Trailing twelve-month revenue of AUD 6.23 million indicates growth potential
  • Net income for the latest quarter was AUD 126,684, a positive shift
  • Current ratio of 1.10 suggests adequate short-term financial health
Anagenics Limited operates in a competitive market, focusing on innovative products that cater to the growing demand for health and beauty solutions. The company's recent financial performance indicates a positive trajectory, with increasing revenue and improved profit margins. The strategic focus on expanding distribution channels and enhancing product offerings positions Anagenics for potential growth in the wellness sector. Investors may find the company's commitment to quality and innovation appealing as it navigates the evolving landscape of health and beauty products.
AI Generated • Jul 17, 2026

Industry

Personal Products

CEO

Karen Anne Matthews

Headquarters

Sydney, NSW 2000, AU

AN1 Financials

Key Financial Metrics (TTM)

Gross Margin

44.72%

Operating Margin

-3.09%

Net Income Margin

-13.73%

Return on Equity

-31.48%

Return on Capital

-49.34%

Return on Assets

-15.75%

Earnings Yield

-23.31%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

A$5.91MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

985.45M

Volume

0

Avg. Volume

436.30K

Financials (TTM)

Gross Profit

A$4.91M

Operating Income

-A$2.99M

EBITDA

-A$2.65M

Operating Cash Flow

-A$3.01M

Capital Expenditure

-A$25.93K

Free Cash Flow

-A$3.04M

Cash & ST Invst.

A$294.30K

Total Debt

A$986.80K

Anagenics Ltd Performance Analysis

Anagenics Ltd annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-06-30AUD 6,945,381N/A
20232023-06-30AUD 9,113,41431.2%
20242024-06-30AUD 10,803,16818.5%
20252025-06-30AUD 5,118,798-52.6%
Anagenics Ltd sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42024-06-30-26.6%
Q22024-12-30-41.3%
Q42025-06-30-23.2%
Q22025-12-3127.8%
Anagenics Ltd annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-06-30AUD -0.02N/A
20232023-06-30AUD -0.01-42.2%
20242024-06-30AUD -0.0288.0%
20252025-06-30AUD -0.00-86.2%
Anagenics Ltd sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42024-06-30-165.4%
Q22024-12-3085.5%
Q42025-06-3070.0%
Q22025-12-31133.3%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

A$2.64M

-57.7%

Gross Profit

A$1.40M

-46.2%

Gross Margin

53.20%

N/A

Market Cap

A$5.91MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

A$537.52K

N/A

Employees

11

N/A

Net Income

A$126.68K

+106.5%

EBITDA

A$428.32K

+141.1%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

A$294.30K

-78.2%

Total Debt

A$986.80K

+13.2%

Accounts Receivable

A$726.52K

+2.5%

Inventory

A$993.02K

-68.9%

Long Term Debt

A$0.00

-100.0%

Short Term Debt

A$986.80K

+86.1%

Return on Assets

-15.75%

N/A

Return on Invested Capital

-6.38%

N/A

Free Cash Flow

-A$661.27K

+37.8%

Operating Cash Flow

-A$649.97K

+33.7%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
SKN.AXSkin Elements Limited
A$0.01+10.00%
8IH.AX8I Holdings Limited
A$0.01+0.00%
ERG.AXEneco Refresh Limited
A$0.02-15.79%
PFT.AXPure Foods Tasmania Limited
A$0.02+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
PLTRPalantir Technologies
$160.94+0.28%
AMIXAutonomix Medical
$10.55+1.89%
NOKNokia
$9.99+0.07%
INTCIntel
$100.17+0.10%

Questions About AN1

What is the current price of Anagenics Ltd?

Anagenics Ltd is trading at A$0.01 per share.

What is the 52-week range for Anagenics Ltd?

Over the past 52 weeks, Anagenics Ltd has traded between A$0.00 and A$0.01.

How much debt does Anagenics Ltd have?

As of the most recent reporting period, Anagenics Ltd reported total debt of A$848.05K.

How much cash does Anagenics Ltd have on hand?

Anagenics Ltd reported A$395.52K in cash and cash equivalents in its most recent financial results.

What is Anagenics Ltd’s dividend yield?

Anagenics Ltd does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.